Article History
Received: 21 October 2020
Accepted: 4 February 2021
First Online: 11 February 2021
Change Date: 14 April 2021
Change Type: Update
Change Details: The original article was missing a statement declaring the funding enabled by Projekt DEAL. The article has been updated to include this funding declaration.
Ethics approval and consent to participate
: The study was approved by the local ethics committee (20-9322-BO).
: Not applicable.
: Andreas Kribben has received grants for clinical studies, speaker’s fees, honoraria, and travel expenses from Actelion, Amgen, Amicus, Alexion, Astellas, Bayer, Baxter, Binding Site, Bristol Myers, Chiesi, CytoSorbents, Fresenius, GlaxoSmithKline, Hexal, Janssen, Kyowa Kirin, MSD, Novartis, Otsuka, Peripal, Pfizer, Roche, Sanofi, Shire, Teva, and Vifor Fresenius Medical. No other author received financial support for researching, writing, or publishing this manuscript.